M
Marsha Wills-Karp
Researcher at Johns Hopkins University
Publications - 193
Citations - 22774
Marsha Wills-Karp is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Interleukin 13 & Immune system. The author has an hindex of 67, co-authored 190 publications receiving 21686 citations. Previous affiliations of Marsha Wills-Karp include Johns Hopkins University School of Medicine & Cincinnati Children's Hospital Medical Center.
Papers
More filters
Journal ArticleDOI
Interleukin-13: Central Mediator of Allergic Asthma
Marsha Wills-Karp,Jackie Luyimbazi,Xueying Xu,Brian Schofield,Tamlyn Neben,Christopher L. Karp,Debra D. Donaldson +6 more
TL;DR: In this paper, the type 2 cytokine IL-13, which shares a receptor component and signaling pathways with IL-4, was found to be necessary and sufficient for the expression of allergic asthma.
Journal Article
Interleukin-13: Central mediator of allergic asthma
Marsha Wills-Karp,Jackie Luyimbazi,Xueying Xu,Brian Schofield,Tamlyn Neben,Christopher L. Karp,Debra D. Donaldson +6 more
TL;DR: In this article, the type 2 cytokine IL-13, which shares a receptor component and signaling pathways with IL-4, was found to be necessary and sufficient for the expression of allergic asthma.
Journal ArticleDOI
Immunologic basis of antigen-induced airway hyperresponsiveness
TL;DR: Current understanding of the pathophysiologic mechanisms by which Th2 cytokines induce airway disease, and the factors that predispose to the generation of these pathogenic cells in response to inhalation of ubiquitous aero-allergens are discussed.
Journal ArticleDOI
The germless theory of allergic disease: revisiting the hygiene hypothesis
TL;DR: It is discussed why a broader 'counter-regulatory' model is preferred — one that might also explain the increasing incidence of autoimmune disease in westernized countries.
Journal ArticleDOI
Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein
Aurelien Trompette,Senad Divanovic,Alberto Visintin,Carine Blanchard,Rashmi S. Hegde,Rajat Madan,Peter S. Thorne,Marsha Wills-Karp,Theresa L. Gioannini,Jerry P. Weiss,Christopher L. Karp +10 more
TL;DR: The results indicate that Der p 2 tends to be targeted by adaptive immune responses because of its auto-adjuvant properties, suggesting that intrinsic adjuvant activity by such proteins and their accompanying lipid cargo may have some generality as a mechanism underlying the phenomenon of allergenicity.